ART with long-term effects without immunosuppression

Published Date: 02 Mar 2023

The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?

2.

Report reveals lung cancer is the leading cause of cancer deaths in Florida

3.

FDA Expands Approval of Osimertinib in Lung Cancer

4.

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

5.

Venetoclax Combo Shows Promise in Younger Patients With AML


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot